Objective
Ras genes take a center stage in signal transduction and molecular oncology, where Ras-driven signaling pathways control proliferation, differentiation, cell adhesion, apoptosis, and cell migration. Mutations in RAS are very common in cancer, and have been found in 20-30% of all human tumors. Moreover, constitutive Ras activation is known to trigger senescence in the absence of “second hit” mutations (e.g. loss of p53). Interestingly, both processes - cancer progression and oncogene-induced cellular senescence - were shown to be dependent on Ras interaction with phosphoinositide 3-kinase (PI3K), which points to a dominant role of Ras-mediated PI3K activation in proliferative disease.
Here we propose to investigate the possibility that Ras/PI3K interactions are dynamically regulated, which is supported by preliminary data: in certain cellular states, post-translational modification of Ras disrupts its binding to PI3K.
We aim to elucidate the importance of this process in physiology and disease. We assume that regulated Ras interactions with PI3Kalpha act in cancer progression, while Ras/PI3Kgamma complexes transiently regulate inflammatory processes. Along these lines, we aim to uncover cellular signaling networks that dynamically dissociate Ras from PI3K. When the above mechanism is validated, we plan to study the consequences of the abrogation of Ras/PI3K interactions in “in vivo” mouse models. These will elucidate if and how PI3K detachment from Ras acts as a a general and central mechanism to balance inflammatory cell recruitment, oncogen-mediated metastasis, proliferation and senescence.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- natural sciences biological sciences cell biology
- natural sciences biological sciences genetics mutation
- medical and health sciences clinical medicine oncology
- medical and health sciences basic medicine physiology
You need to log in or register to use this function
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2009-IIF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
4051 Basel
Switzerland
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.